Efficient CAR T cell manufacturing using a closed and integrated instrument workflow

Overview
This application note built a closed workflow from the CTS DynaCellect and Rotea systems, with electroporation on the Xenon, to edit anti-CD19 CAR T cells from a healthy-donor leukapheresis. Cells cultured in G-Rex®100 vessels grew from about 1 × 10^8 to 2 × 10^9 edited cells, with viability averaging about 85% at day 10.
What this paper found
A closed, integrated workflow linking the CTS DynaCellect, Rotea and Xenon systems produced gene-edited anti-CD19 CAR T cells from healthy-donor leukopaks with high viability. T cells isolated with CD3/CD28 magnetic beads were cultured for 3 days in OpTmizer Pro SFM with 100 U/mL IL-2, debeaded, washed on the Rotea system, and transferred through a welded PVC line to the Xenon system for Cas9 electroporation with a CD19 CAR DNA payload. On day 3 viability exceeded 90% and T cell content averaged 95%. After electroporation, viability averaged about 85% at day 10; about 25% and 30% of cells were CAR-positive without T cell receptor on days 3 and 10, and cultures expanded from about 10^8 to 2 × 10^9 edited cells. Results represent three independent runs.
Note: Proof-of-concept study with cells from healthy donors; the authors note that a complete physical connection of the DynaCellect, Rotea and Xenon systems is a possible future study.
T cells electroporated using this closed and integrated method resulted in an average of 2 × 10^9 anti-CD19 CAR T cells, with high viability.
Study details
- Year
- 2023
- G-Rex® model(s)
- G-Rex®100
- Cell type(s)
- CAR T Cells
- Study phase
- Preclinical
How G-Rex® was used
Healthy-donor T cells isolated from thawed leukopaks with the CTS DynaCellect system and CD3/CD28 magnetic beads (3:1 bead-to-cell ratio) were cultured in G-Rex®100 bioreactor vessels. The culture medium was CTS OpTmizer Pro SFM supplemented with 100 U/mL IL-2. After 3 days of culture, the cells were debeaded on the DynaCellect system, washed and buffer-exchanged on the CTS Rotea system, and sent through a welded PVC line to the CTS Xenon system for electroporation. Debeaded cultures showed over 90% viability and about 95% T cell content.
Explore related
Building a similar workflow?
Talk to a ScaleReady specialist about how the G-Rex® platform can support your program — from process development to clinical-scale manufacturing.